IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events
IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…